Predictors of persistent inflammation in familial Mediterranean fever and association with damage
- 10 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 60 (1), 333-339
- https://doi.org/10.1093/rheumatology/keaa378
Abstract
Objective Persistent inflammation is an insidious and less studied feature of FMF. We investigated clinical determinants of persistent inflammation and its associations with individual damage items. Methods This is a cross-sectional analysis of 917 FMF patients, who fulfilled the Tel Hashomer criteria and had at least 6 months’ follow-up. Patients were stratified based on whether they had persistent inflammation. We used logistic regression analysis to investigate independent predictors of persistent inflammation and the associated individual damage items. Results One hundred and forty-two (15%) patients had persistent inflammation. Active FMF (54%) was the most prominent reason for the persistent inflammation. Spondylarthritis (16%), other inflammatory arthritis (8%) and IBD (2%) were other frequent reasons. Male gender, history of exertional leg pain, inflammatory comorbidities, M694V homozygosity, colchicine resistance, lower education levels and musculoskeletal attack dominance were found to be the independent predictors of persistent inflammation. Earlier disease onset led to a tendency towards persistent inflammation. Patients with persistent inflammation were more likely to suffer damage. There is an increased risk of developing proteinuria, amyloidosis and renal insufficiency. Conclusion We identified, for the first time, the predictors of persistent inflammation in adult FMF patients and related individual damage items of the Autoinflammatory Disease Damage Index. Persistent inflammation is insidious and one of the chief causes of damage; therefore, especially patients with these predictors should be followed up more closely. If detected, underlying inflammatory comorbidities should be assessed meticulously as early detection and proper treatment strategies may favourably impact the natural history of the disease.Keywords
Funding Information
- Hacettepe Rheumatology Association (HRD2018-001)
This publication has 32 references indexed in Scilit:
- High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connectionArthritis Research & Therapy, 2013
- Guidelines for the genetic diagnosis of hereditary recurrent feversAnnals Of The Rheumatic Diseases, 2012
- Chronic inflammation in FMF: markers, risk factors, outcomes and therapyNature Reviews Rheumatology, 2010
- Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapyBritish Journal of Haematology, 2009
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory DiseaseAnnual Review of Immunology, 2009
- The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β productionProceedings of the National Academy of Sciences of the United States of America, 2006
- THE ANEMIA OF FAMILIAL MEDITERRANEAN FEVER DISEASEPediatric Hematology and Oncology, 2005
- Bone mineral density in children with familial Mediterranean feverClinical Rheumatology, 2004
- The spectrum of Familial Mediterranean Fever (FMF) mutationsEuropean Journal of Human Genetics, 2001
- Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean FeverCell, 1997